Stepwise Stem Cell Differentiation for Kidney Structure Formation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to successfully induce a three-dimensional kidney structure from pluripotent stem cells, specifically due to the complexity of kidney development and the lack of clear methodologies for forming functional units like the glomerulus and renal tubule, which are essential for renal function.
Innovation Solution
A method involving step-wise differentiation of pluripotent stem cells using specific growth factors such as Bmp, activin, retinoic acid, and Wnt agonists to induce metanephric nephron progenitor cells, which can reconstruct the kidney's three-dimensional structure, including glomeruli and renal tubules, by maintaining cells in a T-positive undifferentiated state and gradually reducing Wnt agonist concentration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional differentiation methods are used to induce kidney structures from pluripotent stem cells, then general tissue formation may be achieved, but successful formation of functional three-dimensional kidney structures including glomerulus and renal tubule has not been achieved
Solution Approach 1:
The differentiation process is divided into distinct temporal stages with specific growth factor combinations. The method segments the complex kidney development into manageable phases: initial mesoderm induction, intermediate mesoderm formation, and metanephric nephron progenitor cell differentiation, each with optimized factor concentrations and durations
Solution Approach 2:
The invention systematically varies multiple parameters including growth factor concentrations (BMP, Wnt, FGF, retinoic acid), culture conditions, and temporal sequences to optimize differentiation. Specific parameter ranges are identified that reliably produce functional kidney structures, transforming an unreliable process into a controlled methodology
2Ease of manufacture
If the kidney development process is simplified for in vitro induction, then the methodology becomes more feasible, but the essential three-dimensional structure including both glomerulus and renal tubule cannot be properly formed
Solution Approach 1:
The method performs preliminary actions by pre-establishing specific cell states and expressing key transcription factors (such as Osr1) before final differentiation. This preparatory phase ensures that cells are primed correctly to form the complex three-dimensional nephron structure, making the subsequent differentiation more reliable and structurally accurate
3Reliability
If detailed control of differentiation steps is implemented to achieve proper kidney structure, then functional nephron formation is possible, but the process becomes extremely complex and difficult to implement
Solution Approach 1:
The differentiation protocol employs periodic action through cyclic changes in growth factor concentrations and combinations at specific time intervals. This rhythmic modulation of signaling factors mirrors natural developmental patterns and achieves reliable functional kidney structure formation through a more manageable temporal sequence rather than continuous complex control
Data Source
Figure 1~4C
Figure 5D~6
Figure 7
AI summary
The purpose of the present invention is to provide a process or method that can be utilized when deriving a three-dimensional structure of a kidney from pluripotent stem cells such as ES cells or iPS cells. The differentiation inducing method is characterized by culturing pluripotent cells with the following three steps, in order: (a) a step of culturing an embryoid body induced from the pluripotent stem cells in medium containing Bmp4 and a high-concentration (concentration A) Wnt agonist; (b) a step of culturing the embryoid body in medium which contains activin, Bmp4, retinoic acid and a middle-concentration (concentration B) Wnt agonist; and (c) a step of culturing the embryoid body in medium containing Fgf9 and a low-concentration (concentration C) Wnt agonist (herein, the Wnt agonist concentrations is concentration A > concentration B > concentration C).